Pediatr. praxi. 2012;13(5):304-310

Immunotherapy in children with reccurent respiratory tract infections

doc.MUDr.Vít Petrů, CSc.
Centrum alergologie a klinické imunologie, Nemocnice Na Homolce, Praha

Reccurent respiratory tract infections in children are associated with significant morbidity and are one of the most common reasons

for physician visits and hospitalisation. Children with recurrent respiratory tract infections represent a great challenge for the paediatrician,

from both therapeutic and preventive standpoints. He must first determine whether these recurrent infections are because of

host-derived factors (inherited, acquired), or are the result of increased environmental exposure. Host-derived factors may be nonimmunological

or related to host immunodeficiency. Treatment and prevention of these infections has its own rules and should consist of

early, aimed antibiotic therapy acute attacks of infection (if indicated), long and appropriate reconvalescence, elimination of all possible

focuses and origins of infection. There are several possibilities of immunomodulating therapy. The prescription and application of each

immunomodulation agent should be performed in correct manner only in indicated cases with individual approach to each child taking

into account all the rules of immunomodulation therapy.

Keywords: reccurent respiratory infection, immunomodulation

Published: November 1, 2012  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Petrů V. Immunotherapy in children with reccurent respiratory tract infections. Pediatr. praxi. 2012;13(5):304-310.
Download citation

References

  1. Jeseňák M, a kol. Recidivujúce infekcie dýchacích ciest a imunomodulácia u detí. Praha: Mladá fronta (Aeskulap), 2012: 631.
  2. Bystroň J. Využití bakteriálních lyzátů v klinické praxi. Pediatr praxi 2011; 12(6): 398-404.
  3. Rennerová Z, a kol. Baktériové imunomodulátory, In: Jeseňák M, a kol. Recidivujúce infekcie dýchacích ciest a imunomodulácia u detí. Praha: Mladá fronta (Aeskulap), 2012: 226-237.
  4. Špičák V. Imunoterapie a imunomodulace. In: Petrů V, a kol. Dětská alergologie. Praha: Mladá fronta (Aeskulap), 2012: 142-146.
  5. Hrubiško M. Imunoterapia v ambulantnej praxi - čo možeme očakávať od chemických imunomodulátorov? Ambul terapia 2009; 7(1): 6-9.
  6. Kitzler I, Ferreira Branco AP, Villiger B, et al. Immunomodulating treatment of recurrent respiratory tract infections. A multinational post-approval study with Luivac/Passpat oral. J Pharmacol Ther 2002; 11(5): 134-141.
  7. Bystroň J, Petrů V, Krčmová I, a kol. Účinnost a bezpečnost perorálního bakteriálního imunomoduátoru Olimunovac u pacientů s častými infekcemi dýchacích cest. Alergie 2011; 13(1): 58-65.
  8. Jílek D. Klinické a farmakoekonomické aspekty bakteriální imunomodulace. Med pro praxi 2009; 6(1): 53-54.
  9. Razi CH, Harmanci K, et al. The immunostimulant OM-85 BV prevents wheezing attacks in preschool children. J Allergy Clin Immunol 2010; 128: 763-769. Go to original source... Go to PubMed...
  10. Bystroň J, Petrů V, Kopecká K, a kol. Vliv dialyzovaného extraktu vepřových lymfocytů Imunor na klinický stav a základní laboratorní parametry imunity pacientů s recidivujícími či chronickými infekcemi. Alergie 2007; 9(1): 61-68.
  11. Abaffyová Z. Nukleotidy. In: Jeseňák M, a kol. Recidivujúce infekcie dýchacích ciest a imunomodulácia u detí. Praha: Mladá fronta (Aeskulap), 2012: 98-101.




Pediatrics for Practice

Madam, Sir,
please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

I declare:

  1. that I have met the above instruction
  2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited


No

Yes

If your statement is not true, please be aware
that brings the risk of danger to their health or the health of others.